Cargando…

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes

Dengue virus (DENV) infection causes dengue fever, dengue hemorrhagic fever and dengue shock syndrome. It is estimated that a third of the world’s population is at risk for infection, with an estimated 390 million infections annually. Dengue virus serotype 2 (DENV2) causes severe epidemics, and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallichotte, Emily N., Baric, Thomas J., Yount, Boyd L., Widman, Douglas G., Durbin, Anna, Whitehead, Steve, Baric, Ralph S., de Silva, Aravinda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843351/ https://www.ncbi.nlm.nih.gov/pubmed/29481552 http://dx.doi.org/10.1371/journal.ppat.1006934

Ejemplares similares

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
por: Widman, Douglas G., et al.
Publicado: (2017)

A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
por: Gallichotte, E. N., et al.
Publicado: (2015)

Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone
por: Gallichotte, Emily N., et al.
Publicado: (2017)

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization
por: Gallichotte, Emily N., et al.
Publicado: (2018)

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines
por: Swanstrom, Jesica A, et al.
Publicado: (2019)

Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees
por: Martinez, David R., et al.
Publicado: (2020)

Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization
por: Messer, William B., et al.
Publicado: (2012)

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
por: Gallichotte, Emily N., et al.
Publicado: (2019)

Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
por: Wahala, Wahala M. P. B., et al.
Publicado: (2010)

Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas
por: Andrade, Daniela V., et al.
Publicado: (2019)

Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes
por: Andrade, Daniela V., et al.
Publicado: (2017)

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
por: White, Laura J., et al.
Publicado: (2021)

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus
por: Swanstrom, J. A., et al.
Publicado: (2016)

A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans
por: Nivarthi, Usha K., et al.
Publicado: (2021)

Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
por: Zhu, Deanna R., et al.
Publicado: (2023)

In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers
por: Metz, Stefan W., et al.
Publicado: (2017)

A Reverse Genetics Platform That Spans the Zika Virus Family Tree
por: Widman, Douglas G., et al.
Publicado: (2017)

Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model
por: Nivarthi, Usha K., et al.
Publicado: (2019)

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
por: Collins, Matthew H., et al.
Publicado: (2017)

A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity
por: Young, Ellen, et al.
Publicado: (2023)

Corrigendum to ‘‘Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model’’ [EBioMedicine 41 (2019) 465–478]
por: Nivarthi, Usha K., et al.
Publicado: (2020)

Efficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses
por: Cockrell, Adam S., et al.
Publicado: (2017)

Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands
por: Lindesmith, Lisa C., et al.
Publicado: (2019)

Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies
por: Kudlacek, Stephan T., et al.
Publicado: (2021)

Neutralization mechanism of a highly potent antibody against Zika virus
por: Zhang, Shuijun, et al.
Publicado: (2016)

Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes
por: Mattia, Kimberly, et al.
Publicado: (2011)

Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus
por: Chaudhury, Sidhartha, et al.
Publicado: (2017)

Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
por: de Alwis, Ruklanthi, et al.
Publicado: (2014)

Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III
por: Ji, Guang-Hui, et al.
Publicado: (2015)

Renilla Luciferase as a Reporter to Assess SARS-CoV mRNA Transcription Regulation and Efficacy of ANTI-SARS-CoV Agents
por: Roberts, Rhonda S., et al.
Publicado: (2006)

Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity
por: Dinnon III, Kenneth H., et al.
Publicado: (2019)

Sars Cov Replication and Pathogenesis in Human Airway Airway Epithelial Cultures
por: Sims, Amy C., et al.
Publicado: (2006)

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
por: Fibriansah, Guntur, et al.
Publicado: (2015)

Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform
por: Graham, Rachel L., et al.
Publicado: (2018)

Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B
por: Wang, Kang, et al.
Publicado: (2020)

Construction of SHIVs expressing quaternary neutralization epitopes in Env and mimicking the neutralization phenotype of typical HIV-1 isolates
por: Theis, JF, et al.
Publicado: (2012)

Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection
por: Auerswald, Heidi, et al.
Publicado: (2021)

Characterization of a Pathogenic Full-Length cDNA Clone and Transmission Model for Porcine Epidemic Diarrhea Virus Strain PC22A
por: Beall, Anne, et al.
Publicado: (2016)

Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection
por: Comar, Courtney E., et al.
Publicado: (2019)

Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype
por: Metz, Stefan W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fcjv0p994od9var6ftaco8hucq